BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 14, 1999
View Archived Issues
Disappointing results in colorectal cancer patients treated with ledoxantrone
Read More
Sugen speeds development of lead angiogenesis inhibitor
Read More
Asta Medica files for approval of LHRH antagonist and establishes marketing partnership
Read More
Substance P antagonist reduces pain in dental surgery patients
Read More
Human mindin polypeptides and polynucleotides for angiogenic diseases
Read More
Licensing opportunity from RCT: VZV subunit vaccine
Read More
Mitsubishi sets up marketing network for cholesterol-binding agent; launch anticipated this year
Read More
Vanadium complexes claimed by Angiotech for wide range of proliferative disorders
Read More
Kyowa Hakko expands R&D activities overseas
Read More
Cephalosporin prepared by Korean research team shows promise as lead for further optimization
Read More
Toyama, Showa expand periodontitis collaboration
Read More
Mechanism of hypoglycemic activity of YM-268 investigated further
Read More
Independent panel recommends that pivotal Flocor trial for sickle cell crisis proceed
Read More
German academics uncover hormonal mechanism involved in sleep-wake cycles
Read More
Provir to be provided to certain AIDS patients in open-label trial
Read More
CPMP recommends approval of higher dosage form of Rebif
Read More
Telik and Cor Therapeutics enter drug screening and licensing agreement
Read More
FDA advisory panel recommends conditional approval of first nonlaser surgical treatment for myopia
Read More
Development of cancer treatments targeting apoptosis focus of Idun-Abbott agreement
Read More
Extensive toxicity testing conducted on HMG-CoA reductase inhibitor
Read More
Medarex and Centeon begin phase II study of MDX-33 as ITP treatment
Read More
New antifungal agent approved for marketing in The Netherlands
Read More
TKT and Sumitomo collaborate to commercialize Fabry's disease treatment in Asia
Read More
Global FluMist collaboration announced by Aviron and Wyeth Lederle Vaccines
Read More
Another cancer indication targeted for Genta's G-3139: non-Hodgkin's lymphoma
Read More
IntraBiotics begins phase II clinical trial of ramoplanin ointment
Read More
Traditional Chinese medicine shows potential as Rx for hypercholesterolemia
Read More
Results presented from early clinical study of naked gene transfer as therapy for angina
Read More